Riskpilot← Back to searchSign inGet full accessSJØKANTEN LEGESENTER AS
ASActiveOrg 995956284Verkstedveien 1, 9406 HarstadGeneral medical practice activities · NACE 8621Est. 20107 employeeswww.sjokantenlegesenter.no
Revenue 2024
NOK 6,2M
+16% vs 2023
EBITDA margin
0.0%
+100% vs 2023
Equity ratio
56.6%
Financial strength
Net profit 2024
NOK -166K
+79% vs 2023
| Revenue | NOK 6,2M | +16% |
| EBITDA | NOK -2K | +100% |
| Net profit | NOK -166K | +79% |
| Total assets | NOK 2M | -7% |
| Equity | NOK 1,1M | -22% |
| Employees | 7 | — |
Legal name
SJØKANTEN LEGESENTER AS
Org number
995956284
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. september 2010
Share capital
NOK 250 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Forestå drift av fem legekontor med listepasienter iht fastlegeforskriften og tilhørende regelverk. I tillegg skal en del av legevirksomheten benyttes til utplassering av turnuskandidat.
Address
Verkstedveien 1, 9406 Harstad
Phone
+4777000900
Email
post@sjokanten.nhn.no
Website
www.sjokantenlegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 330 | 6 098 | 6 239 | 5 354 | 6 225 |
| Staff expenses | −2 152 | −2 261 | −2 219 | −2 643 | −2 994 |
| EBITDA | 677 | 987 | 1 324 | −642 | −2 |
| Depreciation & amort. | −140 | −191 | −170 | −174 | −161 |
| EBIT | 537 | 796 | 1 155 | −815 | −163 |
| Net financials | −43 | −71 | −29 | −13 | −3 |
| Profit before tax | 494 | 725 | 1 125 | −828 | −166 |
| Tax | −0 | 104 | 248 | −33 | −0 |
| Net profit | 494 | 621 | 878 | −795 | −166 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 388 | 2 671 | 3 288 | 2 128 | 1 984 |
| Equity | 669 | 1 357 | 2 084 | 1 439 | 1 123 |
| Long-term debt | 1 022 | 454 | 33 | 0 | 0 |
| Short-term debt | 697 | 859 | 1 171 | 689 | 861 |
| Total debt | 1 719 | 1 314 | 1 204 | 689 | 861 |
EBITDA margin
-0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
56.6%
This company
38.2%
Market median
+48% vs market
20202024
Return on equity
-14.8%
This company
18.4%
Market median
-180% vs market
20202024
Net profit margin
-2.7%
This company
8.1%
Market median
-133% vs market
20202024
Asset turnover
3.14×
This company
1.12×
Market median
+180% vs market
20202024
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15.2% | 15.2% | 2024 | |
| Individual | 15.2% | 15.2% | 2024 | |
| Individual | 15.2% | 15.2% | 2024 | |
| Individual | 15.2% | 15.2% | 2024 | |
| Individual | 15.2% | 15.2% | 2024 | |
| Company | 15.2% | 15.2% | 2024 | |
| Individual | 8.8% | 8.8% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SJØKANTEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Alvilde Ingemann | Board of Directors | 0 companies |
| Frank Hilpüsch | Board of Directors | 0 companies |
| Frank Hilpusch | Board of Directors | 0 companies |
| Julie Ekman | Board of Directors | 0 companies |